Pharma & Biotech

Novo Nordisk is sending mixed signals to the market with a puzzling dual approach that has left investors questioning the...

Shares of Viking Therapeutics experienced significant upward momentum, climbing 8.1% to reach $33.90 amid renewed market speculation about potential acquisition...

The pharmaceutical giant Eli Lilly, headquartered in Indianapolis, is facing heightened investor scrutiny. A notable sell-off by key insiders has...

Shares of Viking Therapeutics experienced a substantial rally on Friday, climbing 8.1% as investor enthusiasm built around the company's potential...

Investors in BioNTech are facing renewed uncertainty as Morgan Stanley revises its outlook for the biotechnology firm. The prominent investment...

The biotech firm Ocugen finds itself at the center of a storm, presenting investors with a perplexing mix of encouraging...

The biotechnology sector witnessed another episode of extreme volatility as Viking Therapeutics shares embarked on a dramatic rollercoaster ride this...

Eli Lilly shares faced downward pressure on Friday following the disclosure of a substantial divestment by one of its most...

A New York bankruptcy judge has authorized the sale of Seelos Therapeutics' remaining assets for $22 million, effectively concluding the...

AIM ImmunoTech continues to experience significant downward pressure on its stock value, even as the company achieves critical milestones in...